| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |